Current data has a 15-minute delay. Please / to get real-time quotes.
icon

Abivax

ABVX

ABVX Abivax NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Options
    Financials
    News
    Filings
    Profile
    ABVX Chart
    See on advanced chart >
    All
    D
    W
    M
    5m
    • Volume 106.39k
    • Turnover 784.30k
    • P/E(TTM) --
    • Turnover % 0.19%
    • P/E(Static) --
    • Market Cap 468.85M
    • P/B 3.46
    • Shares 62.93M
    • 52 Week Range
      6.53
      17.02
    • Day Range
      7.15
      7.51

    About

    Abivax Sa is incorporated under the laws of France on December 4, 2013. The company is a clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients...
    • Highlight
      A biotechnology company focused on harnessing the body's natural regulatory mechanisms to modulate the clinical stages of chronic inflammatory diseases
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      10/20/2023
    • Established Date
      12/04/2013
    • Full-time Employees
      61
    • Address
      7-11 boulevard Haussmann 75009 Paris France
    • Tel
      33-1-53830963
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      American Depositary Receipt (Common Stock)

    Option Block Monitor

    You Can Understand Stocks with AI.
    Why NVDA surged 16.40%?
    Because it
    fork
    logo
    AInvest
    Aime Coplilot
    Invest Smarter With AI Power.
    Open App
    All
    QUICK
    Daily
    Weekly
    Monthly
    Minutes
    5 minutes
    15 minutes
    30 minutes
    Ranges
    1 Day
    1 Week
    1 Month
    1 Year
    YTD